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Abstract 
 




Adviser: Professor Diego Loayza 
 
 
Telomeres consist of TTAGGG repeats, which end with a 3’ G-overhang and are bound 
by a six-protein complex, known as Shelterin.  In humans, telomeres shorten at each cell 
division, unless telomerase is expressed and able to add telomeric repeats to the 3’ G-overhang. 
However, for effective telomere maintenance, the DNA strand complementary to that made by 
telomerase must be synthesized. In this study, I focused on the Polα/primase complex, in 
particular the subunits p68 (POLA2, the regulatory subunit) and p180 (Polα, the catalytic 
subunit), and their potential roles at telomeres. I was able to detect p180, p68 and OBFC1, a 
subunit in the CST complex, at telomeres in S phase using chromatin immunoprecipitations. I 
could also show that OBFC1, Shelterin and Polα/primase interact, revealing contacts occurring at 
telomeres. Finally, depletion of p68 by shRNA and p68 and p180 by siRNA, led to increased 
overhang amounts at telomeres. I propose a model in which Polα-primase is important for proper 
telomeric overhang processing, perhaps through fill-in synthesis. These results shed light on 
important events necessary for efficient telomere maintenance and protection. 
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In this chapter I will give an overview of telomeres and the Shelterin complex.  
I will then summarize DNA replication as it relates to telomere function, for which the 
yeast system has been particularly informative. Finally I will outline the focus of my work as it 
relates to telomere DNA replication. 
The structure of telomeres poses a fundamental issue to the cell replication machinery. 
Because of the antiparallel nature of double stranded DNA and the obligate 5’-3’ polarity of 
DNA polymerases, leading strand replication requires only an initial RNA primer to start 
replication. On the contrary, the lagging strand must be repeatedly primed and results in the 
synthesis of short stretches of DNA called Okazaki fragments that can be ligated together once 
the RNA primer is removed. This processing leads to the end replication problem, the inability of 
the replication machinery to carry out the complete replication of the end of the linear 
chromosome, which results in telomere shortening and the consequent inhibition of cell division 
and senescence [1]. In addition, telomeres end with an overhang that requires a specific 
processing of the telomeric DNA, which involves the coordination of different factors. I 
postulate that, at mammalian telomeres, components of the Polα/primase complex function as 
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Telomeres are structures located at the end of linear chromosomes. They consist of 
stretches of repetitive DNA sequences and the complex of specialized proteins bound to them, 
known in mammals as Shelterin (Fig.1)[2]. Telomeres cap the chromosomes and protect them 
from genomic instability [3] The protein components specifically prevent the chromosome end to 
be recognized as DNA damage which would lead to cell cycle arrest or the processing of the 
structure by DNA damage response proteins, resulting in deleterious structures.  
The repetitive nature of telomeres and the lack of coding sequences therein are vital for 
their function in protecting chromosomes from the erosion they undergo during ordinary 
replication in somatic cell division. Telomeres length generally decreases according to the 
number of divisions a cell has undergone, with the exceptions for example of cancer or stem 
cells, where telomerase, a reverse transcriptase specialized in telomeres elongation, is often 
found active [4, 5]. This intrinsic characteristic of telomeres to limit cell proliferation when they 
become too short is considered a tumor suppressor mechanism [6, 7].  
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Figure 1.  Telomeres.   
Telomeres are composed by a duplex region of TTAGGG repeats and an ssDNA G strand. 
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Telomerase 
 
As mentioned telomeres play a crucial role in preventing the ends of the chromosome to 
be recognized as DNA damage and be processed by DNA repair proteins creating structures, like 
end-to-end fusion of chromosomes for example, that could result in chromosome instability [8]. 
Alterations to the telomeres structure or processing can result in apoptosis, senescence, or in 
more severe cases cancer. Telomeres constitute a limit to the replicative potential of cells [9, 10]. 
In fact, owing to the biochemical properties of DNA replication, telomeres shorten at each cell 
division, unless the enzyme telomerase is expressed and active [11]. In telomerase negative cells, 
progressive telomere shortening leads to senescence and cell cycle arrest after approximately 50 
to 70 doublings [12]. Hence telomeres length generally decreases according to the number of 
divisions a cell has undergone. The protection given by the presence of unaltered telomeres is 
extremely important for the health of the cell, and conversely any impairment to this regulatory 
system can be highly deleterious for the chromosomes. In fact, one of the required steps for a cell 
to become tumorigenic is the activation of telomerase or an alternative pathway that ensures the 
maintenance of telomeres, endowing it with infinite replicative potential [13]. Thus in order to 
maintain stable telomere length upon cell divisions [14] telomerase needs to elongate the 3’ end 
telomeres by adding TTAGGG repeats [15].  
Telomerase is a ribonucleoprotein that has a catalytic subunit, TERT, and a RNA 
component, TERC. The RNA component has a region that is complementary to the telomeric 
repeats and can bind to the 3’ G-overhang when it becomes available at specific times during the 
cell cycle. The catalytic subunit, which has a specialized reverse transcriptase activity, can then 
add repeats to the complementary RNA template and elongate the G-strand. The reverse 
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transcriptase subunit is evolutionary conserved, it is expressed from early development and it is 
generally found active only in proliferative cells in the body [16]. In most human somatic cells, 




Telomeric repeats and average telomere length varies among different species. Human 
telomeric DNA consists of a string of six tandem repeats that span a length of 5-15kb.  They are 
composed of a G-rich strand, 5’ TTAGGG 3’, and a complementary C-rich strand, 3’AATCCC 
5’, which together form the double stranded portion of the telomeres. In addition, the G-rich 
strand creates a 3’ overhang that can be extended by telomerase. The overhang is believed to 
have an additional role in the protection of telomeres. In fact, it is instrumental in the formation 
of the T-loop, a structure that conceals the linear chromosome end through the G overhang 
invasion of the telomeric double stranded segment and the creation of a displacement loop, the 
D-loop (Figure 2). While the G-rich strand termination is random, the fate of the final 
nucleotides of the 5’C strand is closely regulated, as the strand ends 80% of the time in -AATC 
5’, and 15% in –AATCC 5’, underlying the need for the cell to keep a tight control on the 
processing of the strand through a mechanism that is not well understood.  






Figure 2.  Telomeric DNA.  
A. Telomeric DNA is constituted by long stretch of double stranded TTAGGG repeats ending in a 
single stranded 3’ G-overhang that can be extended by telomerase, with a 5’ end that 80% of the 
times ends in ATC.  B. A protective structure, the t-loop, can be created catalyzed by TRF2 by 
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Shelterin 
 
In humans the complex formed by six specialized proteins that are uniquely found at 
telomeres has been named Shelterin, as it “shelters” telomeres from lethal events.  The complex 
is composed of six proteins: TRF1, TRF2, RAP1, TIN2, TPP1, and POT1. These proteins are 
involved in telomere maintenance by coating the telomeric DNA and physically protecting it, by 
regulating the length of the telomere itself through a “counting” mechanism, and by modulating 
the interactions of the various accessory factors that contribute to the preservation of functional 
telomeres through end processing [19]. Shelterin allows the cell to discriminate between the 
natural end of the chromosome and DNA breaks and effectively inhibiting the DNA repair 
machinery at telomeres. (Fig.3). As in the case of the telomeric repeats, sets of orthologous 
proteins performing similar tasks are evolutionary conserved, underscoring the importance of the 
complex in chromosome integrity [18].   
Shelterin specialized role at telomeres is due to the specific recognition of its DNA 
binding proteins for telomeric DNA repeats. In fact, three of the Shelterin components directly 
bind DNA, TRF1 and TRF2 bind double stranded repeats and POT1 binds the single stranded 
overhang, in both cases with high sequence specificity.  
TRF1and TRF2, upon DNA binding, constitute a platform onto which the rest of the 
complex can assemble [20]. RAP1 binds exclusively to TRF2, while TIN2 acts as a linchpin for 
the complex by bridging TRF1 and TRF2 and connecting them to TPP1, which in turns recruits 
POT1 to the complex (Fig. 1).  Independent deletions of TRF1 and TRF2 did not affect the 
binding of the other proteins in the complex to telomeres, indicating that each protein may have 
and independent role and possibly be found in complexes independent from each other. Most of 
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TRF1 and TRF2 have been detected mostly chromatin-bound, while the other components have 
been observed also in a soluble form. No direct correlation was observed between the abundance 
of the shelterin components and the average length of telomeres in various cell lines, although 





Figure 3.  Shelterin role at telomeres. 
At telomeres Shelterin functions as a protector of the telomeric DNA, by inhibiting the DNA 
damage response and as a mediator of telomeres elongation, both as a negative and positive 
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TRF1 
 
TRF1, Telomeric Repeat binding Factor 1, was the first protein of the complex to be 
identified because of its affinity for the TTAGGG duplex [23]. TRF1 is composed of three 
domains: an acidic amino-terminus, a dimerization domain and a carboxy-terminal SANT/Myb 
DNA binding domain. TRF1 forms a dimer through its TRF homology (TRFH) domain [24, 25]. 
This domain is also utilized for interaction with other telomeric proteins (TIN2) and telomere 
accessory factors [19]. TRF1 is a negative regulator of telomere length. Its overexpression results 
in telomere shortening, while in cells with active telomerase, depletion of TRF1 leads to 
telomere elongation. Although TRF1 is an essential gene, as early embryonic death was observed 
in mice null for the protein [26], its depletion does not show a severe de-protection phenotype. 
However, the TRF1-conditional knock-out revealed both the nature of telomeres as fragile sites 




TRF2 was identified a few years after TRF1 because of the similarities between the two 
SANT/Myb DNA binding and TRFH domains. Like TRF1, TRF2 binds double stranded 
telomeric DNA as a dimer. Unlike TRF1, TRF2 has a basic amino terminal [28]. 
Notwithstanding the common TRFH protein interaction domain, the two proteins cannot interact 
with each other due to structural constraint [29]. 
TRF2 prevents the recognition of telomeric DNA as double-strand break by fostering the 
creation and stabilization of T-loops [30]. Consequently, its depletion leads to ATM associated 
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DNA damage response, chromosome end-fusions, and p53-induced senescence. Like TRF1, 
TRF2 is essential for embryonic survival and act as a negative regulator of telomere elongation. 




Rap1 is found at telomeres bound to TRF2 in a 1:1 ratio, and it depends on its partner for 
stability and its telomeric localization, with TRF2 deletion resulting in Rap1 protein level 
reduction [32]. Rap1 is composed of three domains: a Myb domain, potentially used for protein 
to protein interaction; an N-terminus BRCT domain; and the Rap1 carboxy-terminal domain 
utilized for TRF2 interaction which also contains a putative nuclear localization signal. [16].  In 
budding yeast, Rap1 has a second Myb domain, binds to double stranded telomeric DNA and it 
is essential for telomere protection and maintenance. Rap1 is essential in the mouse, and its 
removal results in sister telomere exchange, suggesting that the protein could act as a repressor 




TIN2 is considered the linchpin of the Shelterin complex as it joins all three DNA 
binding proteins, TRF1 and TRF2 directly, and POT1 through TPP1. TIN2 can bind to all three 
proteins simultaneously [34, 35]. This is very important for the affinity of TRF1 and TRF2 for 
telomeric DNA. In fact, TIN2 is able to protect TRF1 from ADP ribosylation by Tankyrase1, an 
event that decreases its affinity for the DNA. As for TRF2, the interaction seems to enhance its 
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DNA affinity and stabilize the protein in the complex [34]. TIN2 was identified by a two-hybrid 
screen as a TRF1 interacting factor, to which it binds through the TRFH domain [36]. Mutations 
in TIN2 destabilize the whole Shelterin complex and result in a telomere de-protection 
phenotype, explaining why its absence in mouse results in lethality [37]. The de-protection 
phenotype may be due to TIN2 role in recruiting TPP1, and consequently POT1, at telomeres. 
Altering this interaction results in RPA ssDNA binding protein accumulating at telomeres, which 
eventually brings on the activation of the ATR DNA damage response pathway and other 




TPP1 binds both to TIN2 and POT1, bridging the 3’ G-overhang binding protein to the 
rest of the complex. TPP1 is also important for recruitment of POT1 at telomeres [35]. 
Knockdown of TPP1 results in telomere elongation, which is similar to the phenotype seen in 
POT1 knockdown [35, 39, 40]. These results initially pointed to a role for TPP1 as a negative 
regulator of telomerase. However, it was discovered that TPP1/POT1 also have a positive role in 
telomerase repeat addition, both in terms of recruitment of the reverse transcriptase to telomeres 
and for its processivity [41]. Recent studies have more specifically elucidated the role of TPP1 




POT1 is the only protein in the Shelterin complex that binds to the single stranded 
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overhang [45, 46]. The protein was identified through its homology with TEBPα, the telomeric 
ssDNA binding protein in O. nova [47]. POT1 is composed of three domains: two OB folds, 
necessary for binding to the DNA, and the C-terminal third of the protein, which contains the 
TPP1 binding domain essential for the recruitment of POT1 to the Shelterin complex. 
The role of POT1 was studied by creating deletion mutants for the first OB fold and for 
the C–terminus, and by siRNA and shRNA depletion experiments. Deletion of the C-terminus 
showed the importance of the TPP1-POT1 interaction for the recruitment of the protein to the 
telomeres, as the allele truncated for the C-terminal region, termed POT1ΔC, was not found at 
telomeres but rather accumulated in the nucleoplasm [40]. 
Another informative mutant allele, named POT1ΔOB, lacks the first OB fold and is unable 
to bind the single stranded DNA in vitro [46]. However, POT1ΔOB is fully proficient in binding 
to TPP1 and therefore does localize to telomeres. Overexpression of this allele leads to rapid and 
extensive telomere elongation. The telomere elongation observed with POT1ΔOB showed that the 
DNA binding activity of POT1 exerts a repressive action in cis on telomerase. This observations 
established POT1 role as a negative regulator of telomere length downstream of TRF1 and TRF2 
[48].  
The identification of POT1 as a negative regulator of telomere length was corroborated 
by POT1 depletion studies by shRNA [49]. Upon depletion of about 80% of the protein, 
telomere elongation was observed. This setting uncovered another aspect of POT1 function: 
telomere protection. Upon depletion of POT1, DNA damage proteins were found to converge to 
telomeres, a process indicative of the detection of telomeres as DNA damage resembling double 
stranded breaks [18]. Unprotected telomeres become sites of accumulation for γH2AX, p53BP1, 
MRE11, and MDC1 and these foci are referred to as telomere dysfunction induced foci or “TIFs” 
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[50, 51].  In the case of POT1 depletion, TIF formation did not affect cell growth or chromosome 
integrity [49]. The DNA damage response elicited by POT1 depletion is dependent on the 
specific activation of the ATR pathway, itself induced by the recruitment of RPA to telomeres 
[52, 53] These results indicate that significant depletion of POT1 can occur without a major 
initial impact on cell viability The conclusions drawn from these studies are that the overhang 
binding activity of POT1 bears two important activities: repression of telomerase and the 
protection of telomeres from recognition by the DNA damage machinery [38]. 
POT1 depletion highlighted another important role for the protein, its function in the 
processing of the 5’ C-strand. In humans, it was observed that the 5’ recessed end does not end 
randomly, but end in AATC-5’ eighty percent of the times and in AATCC-5’ fifteen percent of 
the times [49]. This observation revealed a tight regulation of the processing of the overhang, 
leading to a specific 5’ terminal nucleotide, which is still poorly understood. The depletion of 
POT1 leads to a randomization of the 5’ end, underscoring a poorly defined role for POT1 in this 
process. 
 
Lagging strand DNA replication and 5’ end processing 
 
Shelterin proteins, including POT1, are believed to play a role in the replication of the 
telomeric DNA, which is known to present a challenge to replication and has been characterized 
as a fragile site [27]. Significantly, telomere elongation, telomere replication, and 5’ end 
processing are deemed to be highly coordinated. The current model states that once telomeres 
have been replicated, the 5’ end needs to be resected to create a viable template for telomere 
elongation by telomerase and is partially refilled [8]. 
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During active telomere elongation in telomerase positive cells, no significant change is 
observed in mean overhang length [54], suggesting coordination between telomerase and the C-
strand synthesis machinery. Lagging strand synthesis is also of great interest because of its role 
in the end replication problem. 
From studies in yeast and ciliates it has emerged that the processing of the single stranded 
overhang and the 5’ end are strictly regulated [55-57]. In humans, it was observed that while the 
3’ end final nucleotides could be randomly placed, the mechanism of C strand processing 
seemed to be very tightly controlled for both leading and lagging strand. This implies that POT1 
has a key role in the mechanism of the 5’ end determination and in the coordination of the 
various processes at chromosome ends. In the mouse system, the exonucleases Apollo and ExoI 
were found to be important for overhang metabolism through 5’end resection at the leading and 
lagging strands respectively [58].   
However, other players have still not been clearly identified. It has been established that 
the two strands are polymerized by different polymerases and differentially processed during 
replication [59]. In humans, the leading strand terminates in a blunt end that is processed at in 
late S/G2 for the creation of the overhang. On the other, the lagging strand overhang length is 
determined earlier in S phase by the placement of the last RNA primer that remains until the 
overhang final processing [60]. The polymerase complex responsible for lagging strand 
processing is Polα/primase. 
DNA replication and telomere processing studies in yeast and mouse on the effects of 
mutations in the Polα-primase complex showed that they can affect telomere length and that in S. 
cerevisiae Polα/primase components can directly interact with the CST (Cdc13-Ten1-Stn1) 
complex [55, 61]. The CST complex is essential for telomerase recruitment and telomere 
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protection in budding yeast. Specifically, catalytic subunit POL1 (Polα) was shown to interact 
with Cdc13 [62] and the regulatory subunit Pol12 (POLA2) was shown to interact with Stn1 
[55]. In addition, in E. crassus telomerase activity was found to co-purify with Polα [56]. 
Therefore, in yeast and ciliates, there appears to be an intimate connection between telomerase 
and Polα-primase, two activities that are highly conserved in evolution. Interestingly, CST 
homologous proteins have been found in other organisms, including the OBFC1 protein in 
humans. In a recent study, the role OBFC1, identified as the 44 kD components in the 
Polymerase α Accessory Factor complex, has been revealed to increase Polα-primase affinity for 
its substrate and its activity [63]. These data provide further basis for a link between the capping 
and regulation of telomeres by the telomeric proteins and lagging strand synthesis machinery. 
 
The CST complex 
 
Shelterin is not the only mode of capping the telomeres to ensure their stability. The CST 
complex, first found in S. cerevisiae, has recently identified in most eukaryotes [64, 65], where it 
also has a vital role in telomere maintenance and has been shown to protect chromosome ends by 




The CST complex is a heterotrimer that binds directly to the overhang and is important 
for telomere protection and replication. In budding yeast, CST is composed by Cdc13, Stn1, and 
Ten1. In this complex Cdc13 binds to the single stranded telomeric DNA [66, 67] and both to 
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POL1, the catalytic subunit of Polα [62] and the telomeric subunit Est1 [62, 68], which possibly 
mediates the recruitment of telomerase to the telomeres. Among the many deleterious telomeric 
phenotypes observed upon Cdc13 alterations in yeast there are telomere shortening and 
chromosome loss.  A striking phenotype is C-strand degradation, which suggests that Cdc13 
interaction with POL1 may be important for C-strand maintenance and puts Cdc13 and the CST 
complex at the center of yeast telomeric replication (Figure 4). Thus this complex is important 




Figure 4. Models for Shelterin, CST, and Polα/primase interaction 
Telomere replication and protection complexes interaction in S. cerevisiae and vertebrates. From 
[69] 
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In Human 
 
Recently the CST complex was identified in other eukaryotes, like S. pombe [70], 
Arabidopsis [71], and humans [64]. In humans, the complex is formed by: CTC1, a cdc13 like 
protein, OBFC1, the Stn1 homolog, and Ten1. Two of the components of the CST complex have 
been observed and studied in mouse as DNA Polα accessory factors, AAF-132 and AAF-44 [63]. 
The two proteins were co-purified with Polα and further studies elucidated that the accessory 
factors permitted the polymerase to remain on the DNA template between the end of a DNA 
synthesis event and the beginning of a new one, thereby seemingly increasing the processivity of 
the enzyme.  A recent study, done on Xenopus laevis nuclear extracts, confirms the importance 
of the complex for the priming of the DNA, but not in recruiting the complex to the template. 
This study also underscores a possible specific role at telomeres in c-strand fill-in [72]. The role 
of the CST complex in the coordination of telomere elongation in humans was also corroborated 
by the finding that it contributes to limiting telomerase activity at extending telomeres through 
complex interactions with telomerase itself and TPP1/POT1 [73]. In addition, it was recently 
shown that CST may have a role both in general telomeres replication, particularly for longer 
telomeres that represent a challenge for the replication machinery, and specifically in C-strand 
fill in with OBFC1 depletion delaying the processing that leads to the final G-overhang [74]. 
As the CST complex is only transiently found at telomeres, however, it is still not clear if 
it has a more general replication control function or if it has an exclusively telomeric role [72]. It 
is also not clear whether CST needs to interact with Shelterin to exert its role on G overhang 
maintenance. 
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In fact, although interactions between members of the complexes have been observed 
[64, 75], CST can bind to the ssDNA independently from POT1 in vitro or in cell free extracts. 
The interplay between the two sets of proteins may span from the protection/maintenance of the 
3’G-overhang, possibly through competition with RPA, to telomeric length regulation, as both 
TPP1/POT1 are involved in telomerase activation and inhibition [41, 48, 76, 77], through 5’ C-
strand processing based on the CST putative interaction with the Polα/primase complex.  
 




Polα/primase is the complex responsible for initiating de novo eukaryotic replication.  It 
is vital for replication in general and it is essential for the replication of the lagging strand that 
requires numerous rounds of RNA primer synthesis. The complex is composed of four subunits: 
p48, the catalytic primase subunit which associate for with p58 to form an heterodimer; p180 
(Polα), the catalytic polymerase subunit; and p68 (POLA2 or B subunit), the regulatory subunit. 
The complex is composed by four subunits: p48, the catalytic primase subunit which associate 
for with p58 to form an heterodimer; p180 (Polα), the catalytic polymerase subunit; and p68  
(POLA2 or B subunit), the regulatory subunit. 
Initiation of replication relies on primase, an RNA polymerase that has the distinctive ability to 
synthesize an RNA primer that is subsequently extended by DNA polymerases. 
p58 associates with p48 and stabilizes the primase. This heterodimer is responsible for 
laying the 8-12 original RNA primer necessary to start replication [78]. Through a mechanism 
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not well understood the two subunits transfer the processing to the catalytic DNA polymerase 
subunit, p180, which extend the RNA/DNA stretch to 30-35 nucleotides before the strand 
synthesis is passed on to Polε for the leading and Polδ for the lagging strand synthesis [79] p68 is 
not necessary for the enzymatic activity of the primase and the DNA polymerase, but it seems to 
have a role in regulating the complex function during cell cycle and at telomeres [80, 81].  
Because of the antiparallel nature of double stranded DNA and the obligate 5’-3’ polarity 
of DNA polymerases, while leading strand replication requires only an initial priming, the 
lagging strand must be repeatedly primed by the primase and results in the synthesis of Okazaki 
fragments approximately 200 nucleotides that can be ligated together once the RNA primer is 
removed. A screen for genes involved in chromosome end protection done through siRNA 
mediated knock down of over 300 proteins and their concomitant creation of TIF, showed Polα 
has a potential candidate [82] for this function. These results in human cells underscored studies 
done in yeast that identified the necessity of Polα/primase for successful telomeres elongation 




The role of the regulatory subunit of Polα/primase, particularly in humans, is still not well 
understood. Studies have been done mainly on the yeast ortholog or using the SV40 viral 
replication system; nevertheless the data collected expounded the importance of the protein in 
coordinating the complex function. The S. cerevisiae ortholog was found to be required for cell 
viability and to be essential in the early stages of replication at the G1/S point [80], where its 
unphosphorylated form seems to be important for the complex loading and tethering the DNA 
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template [85-87].  p68 (POLA2) phosphorylation throughout S-phase/G2 by Cdk2/Cyclin A and 
its dephosphorylation by the end of M is believed to be important for ongoing lagging strand 
replication and quenching of chromosomal replication. p68 is believed to be critical for loading 
and setting of the primer  [88] and elongation of the early Okazaki fragment, particularly in the 
presence of RPA. An increase in the phosphorylation state of p68 from G1/S to G2/M has been 
observed both in yeast and in humans suggesting a possible mechanism for shutting down 
Polα/primase activity as replication end [81, 88]. Cdk2/Cyclin A phosphorylation of the 
complex, however, seems to have a more intricate role. The complex in fact shows maximum 
activity when p68 is phosphorylated, however, it seems that p180 (Polα) phosphorylation later in 
the cycle abolishes replication initiation [89].  
Of greater interest for telomeric replication, p68 may facilitate the interaction between Polα and 
hyperphosphorylated Rb in the late S-phase. The ppRB- Polα interaction is believed to be 
important for preventing Polα slippage at repeated sequences, which propose a role for p68 in 
enabling replication of C-strand fill in at telomeres in late S-phase while inhibiting non-telomeric 
DNA replication [90]. 
Studies done on the mouse complex show that all four components are present in the cell 
throughout the cell cycle at a basal level. Although the basal transcription of all the components 
is regulated by different transcription factors, the increase in the amount of the proteins induced 
by growth stimulations has been found to be controlled for all four by E2F by a mechanism that 
is not well understood [91-93]. 
In another study on a temperature sensitive form of p180, Eichinger et al. found that the 
p68 subunit was important for the transport of p180 in the nucleus and that when the protein was 
knocked down by siRNA the p180 accumulated in the cytoplasm [94]. 
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In yeast Polα/primase is necessary for successful telomeres elongation and the tight 
regulation between G and C strand synthesis at chromosome ends [83, 84]; however, the role of 
the complex at human telomeres has yet to be determined. 
Different models for the creation of the 3’ G-strand overhang at telomeres have been 
proposed assuming different mechanisms for leading and lagging strand processing due to the 
fundamental properties of DNA replication and telomerase activity [69]. Recently, it has been 
shown that the two strands are in fact differentially processed during replication [60]. This study 
establishes the basis for a distinct processing for the leading vs. lagging strands without, 
however, excluding other additional processing events for the C-strand fill-in.  For example 
differential metabolism for the two terminal strands was observed in studies done in the mouse 
system, in which overhang creation through 5’ end resection was executed at the leading strand 
by Apollo and at the lagging strands by ExoI [58]. This work also elucidated an important role 
for POT1b, one of the two members of the POT protein family in mouse, in both leading and 
lagging strand overhang formation through the coordination of the nucleases and the C strand 
fill-in through association with the CST complex underscoring the role of POT1 in this process.  
As previously stated, CST in yeast has been shown to be involved in overhang processing 
and in humans the complex was isolated as a set of accessory factors for Polα/primase [63]. The 
Polα/primase complex is believed to be responsible for replication of the lagging strand and the 
C-strand fill in for both strands after resection. It has recently been established that telomeres, 
notwithstanding their reported nature of fragile sites of DNA replication, do not undergo a 
telomere specific replication program, but mainly a chromosome-specific one [95]. However, 
partial altering of the replication machinery can have telomere-specific effects. Mouse cells with 
a temperature sensitive Polα, exhibit overhang extension and concomitant overall telomere 
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elongation [61]. Therefore, although defects in DNA replication and in particular in Polα-
primase activity are predicted to affect general chromosomal DNA replication, it is possible that 
this activity displays non-canonical, telomere-specific roles, in particular in overhang processing. 
Our study investigates these roles, and focuses on the roles of p68 (POLA2) and p180 (POLA1) 
in the attempt to elucidate the mechanism that coordinates telomeres maintenance. We 
hypothesize that POLA2, the regulatory subunit of Polα, has an important role in coordinating 
the interaction between the three complexes and ensuring proper telomeres replication.  
In this study I show that both p180 and p68 are present at telomeres in S phase and I 
established a novel interaction between the Shelterin complex and p180 and p68 (Chapter 3). I 
also show that depletion of p180 result in a general DNA damage response, which is not seen 
with p68 (Chapter 4). Notwithstanding the lack of TIFs the function of p180 and p68 were 
revealed to be important for the regulation of telomeric overhang amounts in human cells 
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CHAPTER 2  
 
Materials and Methods 
 
Cell lines and retroviral infection 
 
HeLaII cells are a HeLa subclone used in [21]. The HTC75 cell line is a HT1080 
derivative described in [96].The cells were grown in DMEM/10%BCS, and the retroviral 
transduction protocol was identical to that described in [97]. 
Cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented 
with 10% Bovine Calf Serum (BCS), and 100U/ml penicillin and 0.1mg/ml streptomycin.  
Phoenix cells were grown in DMEM with 10% Fetal Bovine Serum (FBS), 100U/ml penicillin 
and 0.1mg/ml streptomycin. Retroviral transduction was carried out as follow. Phoenix retroviral 
packaging cells were evenly plated at a density of 40%-50%. After 24 hrs they were transfected 
using Calcium phosphate method and 20µg of the desired DNA. Construct. Media was changed 
12 hrs after transfection. The virus-containing supernatant was collected 24, 36, and 48 hrs after 
media change. The supernatant was supplemented with 10% FBS and 4ug/ml polybrene, filtered 
using 0.45 micron filters and used for infection immediately after collection for a total of three 
rounds of infection.  Media was changed for the infected cells 24 hrs after the last infection and 
selection with 2µg/ml puromycin was started 48 hrs after last infection.  The POT1∆OB and 
FLAG-TRF1 constructs and cell lines are described in [48]. 
 




All rabbit sera used were generated against a peptide conjugated to KLH and used for 
immunization into rabbits, as per the protocol set by the manufacturer (BioSynthesis, Lewisville, 
TX).  The peptides were: NH2- GCKGRQEALERLKKAKAGEK -OH for p180, and NH2- 
GCRLYLRRPAADGAERQSP-OH for p68.  The peptide for FEN1 NH2-
GCSTKKKAKTGAAGKFKRGK–OH, for TRF1 NH2-GCGSIEKEHDKLHEEIQNLI-OH (as 
described in [96]), for POT1 NH2-CYGRGIRVLPESNSDVDQLKKDLES (as described in[48]), 
for TPP1 NH2-GCTGPRAGRPRAQARGVRGR-OH, and for OBFC1 NH2-
GCKTKIEIGDTIRVRGSIRT-OH.  The p53BP1 antibody was purchased from Novus (NB100-
304).  The TRF2 antibody used for immunofluorescence was purchased from Millipore, clone 
4A794 (05-521). The p68 and p180 antibodies used for Western blots were purchased from 




 Cells were trypsinized and lysed in cold lysis buffer (50mM Tris-HCl pH 7.4, 20% 
glycerol, 1mM EDTA, 150mM NaCl, 0.5% Triton X-100, 0.02% SDS, 1mM DTT, 2mM PMSF, 
1µg/ml aprotinin, 10µg/ml pepstatin, and 1µg/ml leupeptin). NaCl for a final concentration of 
400mM was added.  After 20 minutes cold deionized water: lysis buffer (v:v) was added and the 
lysate was thoroughly mixed and then centrifuged at max speed, at 4°C, for 10 minutes. 
Supernatants were collected and used immediately for IP. Lysates were mixed with 30µl of crude 
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serum and 5µl of commercial antibodies and rotated at 4°C for 4 hours. 30µl of protein G-
Sepharose beads were added to the samples for 30 minutes. The beads were pre-blocked 
overnight with 10% BSA in PBS. After half an hour the beads were washed three times cold PBS 




The cDNA for p68 (gene name POLA2) was purchased as a full-length clone from the 
EST collection maintained by Invitrogen.  The full-length cDNA was amplified by PCR using 
primers with appropriate cloning sites (5’ BamHI and 3’ EcoRI) and cloned into pLPC-MYC 
(see [97]) to generate a MYC tagged version driven by the CMV promoter.  The PCR 
oligonucleotides were: 5’-TGCTTAGGATCCGCATCCGCCCAGCAGCTG-3’ and 5’-
TGGAGAGAATTCTCAGATCCTGACGACCTGCACAG-3’ corresponding to target sites for 
codons 2-7 at the 5’ end and the last 7 codons of the cDNA including the stop codon.  The 
OBFC1 cDNA was PCR-cloned from a complete EST purchased from ATCC as a template, and 
with the following two oligonucleotides: 5’-
ATAACACAGATCTCAGCCTGGATCCAGCCGGTGTG-3’ and 5’-
TTCACCTCTCGAGTCAGAACGCTGTGTAGTAGTGC-3’, yielding a BglII-XhoI fragment as 
a PCR product.  The TPP1 EST was purchased from Invitrogen and PCR-cloned with the 
following two oligonucleotides 5’-AGGAGGATCCCCTGGCCGCTGTCAGAGTGACG-3’ and 
5’-GAGGACTCGAGTCACATCGGAGTTGGCTCAGAC-3’, yielding a BamHI-XhoI fragment 
as a PCR product. 
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RNA interference  
 
HeLaII cells were maintained in DMEM (Invitrogen) supplemented with 1% penicillin 
and streptomycin and 10% fetal bovine serum (FBS). The siRNAs used were synthesized by 
Dharmacon RNA Technologies. For p68 RNAi, double-stranded siRNA were designed to target 
the following sequences: p68-1 siRNA 5’-UGGAAGAAGAAGAGGAAAUUU-3’ and p68-2 
siRNA 5’-UAUCUGAGCUUAAGGAAUAUU-3’.  For p180: p180-1 siRNA 5’-
CUGAGUACUUGGAAGUUAA-3’; p180-2 siRNA 5’-CAGAUCAUGUGUGAGCUAA-3’; 
p180-3 siRNA 5’-GAGAGUAGCUGGAAUGUAA-3’.  
HeLaII cells were transfected using Lipofectamine (Invitrogen) according to the 
manufacturer’s instructions. Briefly, cells at a confluency of approximately 50-60% were plated 
in a 6-well plate 18-24 hrs prior to transfection. Transfections were done one time within a 24 hr 
interval and cells were processed 48 hr after the first transfection for protein extraction or 
immunofluorescence. As a control siGFP (Dharmacon) was used. 
For shRNA, the LMP vector from Open Biosystems was used, which is based on the 
miR30 miRNA.  The target sequences were PCR cloned according to the manufacturer’s 
protocol based on the NM_002689.2 sequence for the p68 cDNA. The target sequences were: 
sh5’UTR, 5’-
CTCTGCCACCGTCACTGAGAAGTAGTGAAGCCACAGATGTACTTCTCAGTGACGGTG











Immunostaining for p53BP1 and TRF2 was performed for HeLaII cells plated onto glass 
coverslips and processed for RNAi. After the 48 hour transfection period, cells were extracted 
with TX buffer [0.5% Triton X-100, 20mM Hepes-KOH pH 7.9, 50mM NaCl, 3mM MgCl2, 
300mM sucrose] for 10 min at RT. After two PBS washes, the cells were fixed with 3% 
paraformaldehyde, 2% sucrose for 10 min at RT.  After two PBS washes, cells were 
permeabilized with TX buffer for 10 min at RT, washed twice with PBS and blocked with PBG 
[PBS/0.2% fish gelatin, 0.5% BSA] for 30 minutes. Coverslips were then incubated with the 
rabbit anti-p53BP1 antibody (Novus NB100-304A-1), at a concentration of 1:500 in PBG 
overnight. Cover slips were then rinsed three times with PBG solution and incubated with 
secondary TRITC-conjugated goat anti-rabbit antibody (Jackson Immunoresearch) in PBG at a 
concentration of 1:500 for 45 min at RT. Cover slips were rinsed two times with PBG. 
Coverslips were then incubated with PBG and 4,6-diamidino-2-phenylindole (DAPI) at 
100ng/ml to visualize the nuclei. Coverslips were mounted on to slides with embedding media. 
Images were collected with an Olympus BX61 fluorescence microscope using a 60X objective 
connected to a Hamamatsu ORCA-ER CCD camera, controlled by the SlideBook 5.1 image 
capture software. 
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Chromatin Immunoprecipitation (ChIP) 
 
Cells were trypsinized, collected, rinsed with PBS and fixed in 1% formaldehyde in PBS 
for 60 min at room temperature. They were then lysed in 1% SDS, 50mM Tris-HCl, pH 8.0, 
10mM EDTA at a density of approximately 107cells/ml. Lysates were sonicated (cycles of 2 
secs, 50% duty and output of 5) in order to obtain DNA fragments < 1kb. The lysates were 
cleared by 10 min centrifugation max speed at 4°C. For each ChIP sample 200µl of lysate diluted 
in 1.2ml dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2mM EDTA, 16.7mM Tris-HCl, pH 
8.0, and 150mM NaCl) was used. 30µl of the desired crude serum was added to the lysates and 
the samples were rotated overnight at 4°C. 30µl of G4 sepharose beads blocked with BSA and E. 
coli DNA overnight were added to each sample and allowed to rotate for 30 mins at 4°C. The 
beads were then centrifuged and washed in order with Buffer A (0.1% SDS, 1% Triton X-100, 
2mM EDTA, pH 8.0, 20mM Tris-HCl, pH 8.0, 150mM NaCl), Buffer B (Buffer A with 500mM 
NaCl), Buffer C (0.25M LiCl, 1% NP-40, 1% Na-deoxycholate, 1mM EDTA, pH 8.0, 10mM 
Tris-HCl, pH 8.0) and TE buffer (10 mM Tris-HCl, pH 8.0, 1mM EDTA, pH 8.0). The 
immunoprecipitated protein/chromatin was eluted from the beads with 500µl 1% SDS, 0.1M 
Na2CO3. After 20µl 5M NaCl were added to each sample, the reverse crosslinking was 
performed incubating the samples at 65°C for 4 hrs. Two sets of 50µl of cell lysate were 
processed along the immunoprecipitated samples starting at the reverse crosslinking step to 
quantify the total telomeric signal. After reverse crosslinking 20µl of 1M Tris-HCl, pH 6.3 and 
10µl of 0.5M EDTA, pH 8.0 was added to each sample in addition to 20µg DNAse free RNase 
A. The samples were incubated for 30 min at 37°C. Protein in the samples was then digested by 
adding 40µg proteinase K and incubating the samples for 60 min at 37°C. DNA was then 
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extracted using the Phenol/Chloroform/Isoamyl alcohol procedure and precipitated overnight at - 
20°C in 1ml ethanol. The precipitated DNA was resuspended in 100µl of dH2O, denatured at 
95°C for 5 min, and immediately dot blotted onto Hybond membranes in 2X SSC. 80% of the 
sample was loaded for telomeric sequences detection and 10% for non-specific Alu detection.  
Membranes were then treated with Denaturing Buffer (1.5M NaCl, 0.5N NaOH) for 10 minutes 
and Neutralizing Buffer (1M NaCl, 0.5M Tris-HCl, pH 7.0) for 10 minutes. The membranes 
were hybridized with TTAGGG and Alu probe as described in [14]. They were then rinsed three 
times in 2xSSC. The signal on the dot blots was quantified using ImageQuant analysis software 
(GE Healthcare) after exposure at varying times on a PhosphoImager screen. All lysates were 
normalized using the total telomeric DNA signals. The percentage of each immunoprecipitation 
was calculated based on the ratio of the signal relative to the corresponding total DNAs. This 
accounts for cell numbers and changes in telomere length.  
 
In-gel G-overhang assay 
 
Genomic DNA was isolated from cells using PCIA extraction. It was digested AluI and 
MboI. Control samples were digested with ExoI to ensure the signal was derived from the 3’ 
overhang. 4µg of DNA for each sample was loaded on a 0.7% agarose gel in 0.5X TBE. 
Following electrophoresis the gels were dried at room temperature for at least 3 hrs. They were 
then prehybridized with in Church mix (0.5M Na2PO4, pH 7.2, 1mM EDTA, pH 8.0, 7% SDS, 
1% BSA) for 30 minutes at 50°C and hybridized overnight with end labeled (CCCTAA)4 and 
(TTAGGG)4 oligonucleotides 50°C. After hybridization the gels were washed 3X with 4X SCC 
and 1X with 4X SCC, 0.1% SDS at 55°C. They were then exposed overnight to a 
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PhosphoImager screen. To get the total telomere signal the gels were then denatured (0.5M 
NaOH and 1.5M NaCl) for 30 min and neutralized (3M NaCl, 0.5M Tris-HCl, pH 7.0) twice for 
15 minutes, rinsed with dH2O and hybridized with the appropriate end-labeled oligonucleotide. 
The signal was obtained by exposing the gels overnight to a PhosphoImager screen. The signal 
was quantified using ImageQuant analysis software (GE Healthcare) after exposure on a 
PhosphoImager screen. The G-overhang signal was calculated by dividing the native 
(CCCTAA)4, by the same oligo signal from the denatured gel.  
 
Terminal Restriction Fragment (TRF) Southern Blot  
 
Genomic DNA was isolated from cells using PCIA extraction. It was digested AluI and 
MboI overnight. DNA concentration was determined after digestion and 4µg of DNA for each 
sample was loaded on a 0.7% agarose gel in 0.5X TBE. Following electrophoresis the gels were 
soaked sequentially in: depurination buffer (0.25M HCl) for 30 minutes; denaturation buffer 
(1.5M NaCl, 0.5M NaOH) twice for 30 minutes; and neutralization buffer (1M Tris pH7.4, 1.5M 
NaCl) twice for 30 minutes. The gels were then blotted onto Hybond membranes southern 
blotting sandwich overnight in 20X SSC. The DNA was crosslinked to the membrane in the 
Stratalinker for 60 sec. The membrane was then prehybridized with in Church mix (0.5M 
Na2PO4, pH 7.2, 1mM EDTA, pH 8.0, 7% SDS, 1% BSA) for 1 hr at 65°C and hybridized 
overnight TTAGGG probe at 65°C. After hybridization the membranes were washed in Church 
Wash (40mM NaPi pH 7.2, 1mM EDTA pH 8.0, 1% SDS) three times for 15 minutes. They 
were then exposed overnight to a PhosphoImager screen and the gel image was obtained using 
ImageQuant analysis software (GE Healthcare).  
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Cell synchronization and FACS 
 
HeLaII were plated 106 cells in 10cm plates. After 24 hrs, thymidine to a final 
concentration of 2mM was added to the media. The cells were treated with thymidine for 14 hrs, 
and then they were rinsed 3 times with warm PBS and fresh medium without thymidine. The 
cells were released for 11hrs and then thymidine, 2mM final concentration, was added to the 
medium again for the second block. After 14 hours the cells were released as above and collected 
at the appropriate time points for ChIP and FACS. For FACS, cells were collected and rinsed 
twice in cold PBS, resuspended in 0.2mL of PBS/2mM EDTA, 2mL of cold 70% Ethanol was 
added drop wise and the cells were kept at 4°C 24 hrs for fixation. The cells were then spun 
down and resuspended in 0.5ml of PBS/2mM EDTA. 10ul of heat inactivated RNase A 
(10mg/ml) and 25µl of Propidium Iodide (1mg/mL) were added and the cells were incubated at 
37°C for 30 minutes. The samples were then analyzed using a FACSCalibur Flow Cytometer. 
 
Single Telomere Length Assay (STELA) 
 
The terminal nucleotide at C-rich strand was determined by STELA as described (Sfeir et 
al, 2005) with minor modifications. Briefly, 10ng EcoRI digested genomic DNA was ligated to 
each telorette (10-5µM) at 35°C overnight in 10µl ligation reaction containing 1X ligase buffer 
and 200U T4 ligase (NEB). The ligated DNA was diluted to 250pg/µl for subsequent PCRs. 
Multiple PCR reactions (35 cycles 94°C 30 sec, 53°C 30 sec, 72°C 1 min, 72°C 10 min) were 
carried out in 25µl containing 250pg ligated DNA, 0.2mM primers (XpYpE2 forward primer and 
C-Teltail reverse primer), and 2U FailSafe enzyme mix (Epicentre). PCR products were resolved 
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on 0.7% agarose gels in separate lanes. After electrophoresis, the samples were processed as per 
Southern Blot). Signals were detected by PhosphorImager screen (GE healthcare). 
 
Telomeric Repeat Amplification Protocol (TRAP) 
 
 
Telomerase activity in cell lysates was measured as previously described [98] by TRAP 
assay using the TRAPEZE® Telomerase Detection Kit (Chemicon International, Hampshire, UK) 
according to the manufacturer's protocol. After a 30-min incubation at 30°C in the thermal cycler 
PCR amplification was performed (33 cycles: 94°C for 30s, 59°C for 30s, 72°C for 1 min). The 
PCR products were separated by non denaturing PAGE on a 10% gel, stained with Ethidium 
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 CHAPTER 3 
 
Polα /primase components are detected at telomeres and interact 




Factors involved in chromosomal replication have been shown to interact with telomeric 
proteins in various organisms.  In the case of Cdc13 and Stn1, members of the yeast CST 
complex, the interaction was shown to have a direct effect on telomeres protection. The CST 
complex, however, has not been defined yet as an unambiguous telomeric component, with its 
role possibly being extended also to non-telomeric replication. In yeast, overexpression of Stn1 
resulted in protein being found at non-telomeric replication sites through its interaction with 
Pol12 [99]. 
In humans, the discovery of the CST complex suggested that similar interactions were 
possible, as members of the complex were initially characterized as affinity factors for the 
replication machinery [63]. It was recently shown that CST may have a role both in general 
telomeres replication, particularly for longer telomeres that represent a challenge for the 
replication machinery, and specifically in C-strand fill in with STN1 depletion delaying the 
processing that leads to the final G-overhang [74]. In addition to CST, other proteins involved 
with lagging strand DNA have been localized at telomeres.  For example both FEN1 and WRN 
are recruited to telomeres in S phase [100, 101] and required for efficient lagging strand 
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synthesis [102]. These observations are compatible with the view that telomeres constitute a 
“fragile site” on the chromosome that requires specific activities to promote effective replication.  
The Shelterin components are quantitatively associated with telomeres and are present at 
telomeres throughout the cell cycle.  One of the ways Shelterin exerts its roles on telomere 
function is through the transient recruitment of accessory factors [22]. In fact, the complex can 
be viewed for some aspects of telomere function as an assembly platform for such factors.  These 
factors associate with specific Shelterin subunits. Even though some of the molecular 
interactions are well characterized, few such interactions have been documented that pertain to 
C-strand replication.  
I argued that, as it is the case for other factors, also components of the Polα /primase have 
specific telomeric roles independent of their whole genome function. Hence, I sought to 
determine whether the Polα complex could be detected at telomeres in human cells and could be 
shown to interact with Shelterin 
My first goal was to establish whether I could observe localization of proteins from the 
Polα /primase complex at telomeres notwithstanding the transient interaction required during 
replication.  
Upon finding that p180 and p68 could be detected at telomeres, I proceeded to verify if 
interactions between proteins belonging to all three complexes (Shelterin, CST, and 
Polα/primase) could also be detected. I specifically focused on p180, p68 for the Polα complex, 
OBFC1 for the CST and various components of the Shelterin complex. 
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Results 
 
In order to address if p180 and p68 could be detected at telomeres, I performed a 
chromatin immunoprecipitation (ChIP) assay. This technique has been widely used to study 
protein localization at telomeres and was instrumental in establishing Shelterin members as 
specialized telomere components, as it was to determine the telomeric presence of other accessory 
factors such as FEN1 [103] . 
The replication complex has as a genomic-wide role, and its presence at DNA replication 
sites is correlated to cell cycle staging, hence, the assay was carried out on synchronized HeLa II 
cells as well as various asynchronous lines. The immunoprecipitations were realized using anti-
peptide rabbit sera against p180, p68, and OBFC1, the latter being a subunit of the CST complex. 
The membranes were then probed with an 800 bp TTAGGG probe to detect telomeric DNA.  
ChIP done on asynchronous HCT75 control cell lines, and other cancer cells, yielded a 
low but reproducible signal of about 3.5% total for p68, and 0.5% for p180 (Fig. 5).  Shelterin 
components, TRF1 and POT1, were used as positive controls and were as expected visualized at 
telomeres with a yield of 6% and 9%, as well as FEN1, with a yield of 4% total DNA, likely 
representing a S phase population [103].  
As the roles of Polα-primase are primarily related to DNA replication in S phase, I sought 
to determine if the telomeric association of p180, and perhaps also p68, was mostly occurring at 
this stage as was reported for FEN1 [103]. HeLa II cells were synchronized using a double 
thymidine block, and the cells were collected for ChIP and FACS at 0, 2, 4, 6, and 8 hours after 
release (Fig. 6A and B). I found that in S phase cells OBFC1, p68, and p180 could be reliably 
detected at telomeres, albeit at low levels (Fig. 6C).  
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p180 peaked in the early S-phase, about 0.3%, then decreased in the middle of cell 
division to less than 0.1%  and then in late S/G2 return to a 0.2% of total DNA. OBFC1 was seen 
to follow a similar pattern although at different times during the cycle, with a progressive increase 
from 0 to 4 hours, 0.6% to 1.2% to 2% total DNA, a drop at 6 hours to 0.2% to return to 1% in 
late S/G2. p68 on the other hand seemed to be present at telomeres more stably throughout S 
phase, with a low of 0.4% at the beginning of replication, to a peak of 1.4% at 2 hours and then 
stable around 1% for the rest of the cycle. Alu sequences were used as an internal control and 
were found to be between 0.05 to 0.2% for all samples. 
Differences in the total percentage DNA yields at telomeres may indicate different 




















Figure 5. Localization of p68 and p180 to telomeres by chromatin immunoprecipitations in 
HCT75. 
A. ChIP in unsynchronized HTC75 cells. The TTAGGG probe was the telomeric probe, while Alu 
probe was used as a non-telomere control. B. Quantitation of the DNA yields for the HTC75 ChIP. 
Yields were calculated by normalizing the IP signals to the input and subtracting the PI background 
from the complementary S signal. PI: preimmune serum, S: immune serum. POT1 and TRF1 were 
used as positive controls for the telomeric signal. 
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As I was able to detect p180 and p68 at telomeres, I set to investigate a possible 
interaction between these proteins and Shelterin components. I detected these association by 
immunoprecipitation followed by Western blot in established HTC75 stably overexpressing 
tagged Shelterin components, Flag-TRF1, MYC-POT1∆OB , and MYC-POLA2 and newly 






Figure 7. Stable retroviral transduction of OBFC1 and TPP1. 
A. Western Blot showing expression levels for MYC-OBFC1 and MYC TPP1 and FLAG-
OBFC1 and FLAG-TPP1 in HTC75. B. Western Blot showing expression levels for MYC-
OBFC1 in HCT116. 
Blots were probed with anti-MYC antibody (9E10) and anti-FLAG antibody (M2) 
 
Figure 6. Localization of p68 and p180 to telomeres by chromatin immunoprecipitations in 
synchronized HeLaII. 
A. ChIP in synchronized HeLaII cells. Cells were subjected to a double Thymidine block, and 
processed for ChIP at the indicated time points after release.  The TTAGGG probe was the 
telomeric probe, while the Alu probe was used as a non-telomere control. B. FACS profiles 
showing DNA content of the synchronized HeLaII at the indicated time points. C. Quantitation of 
the yields for p180 and p68 between 0-8 hours after release. Yields were calculated by normalizing 
the IP signals to the input and subtracting the PI background from the complementary S signal. PI: 
preimmune serum, S: immune serum.   
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 In the co-immunoprecipitation western blot, done using pre-immune and immune rabbit 
sera for the indicated proteins, I observed an OBFC1 association with POT1, TPP1, and 
POT1∆OB and TRF2 (Fig. 8A and B). Total lysate, beads not treated with lysate, and 
immunoprecipitation with MYC antibody were used as controls. In addition, I was able to show 






Figure 8. Interactions between OBFC1 Shelterin components and Pola components 
detected by IP-Western in HCT116 and HTC75 overexpressing MYC-OBFC1. 
A. Extracts prepared from HCT116 cells expressing MYC-OBFC1 were used for 
immunoprecipitations with the antibodies indicated at the top of the lanes. B. 
Immunoprecipitation in HTC75 expressing MYC-OBFC1 done as explained in A. 
The antibody used to probe the Western blots was anti-MYC 9E10 antibody.  
Quantitation for both experiments was done by subtracting the PI signal from the S signal. PI: 
preimmune serum, S: immune serum. All samples shown for each line were part of the same 
experiment and on the same membrane, except for TRF2 and hTERT for HCT116 and p180 pull 
down for HTC75, which came from the same experiment, but from a different membranes.  
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As it was not clear if p180 or p68 could be found in a complex with Shelterin 
components, I set to see if I could immunoprecipitated MYC-POLA2 with Shelterin proteins. 
Indeed MYC-POLA2 could be pulled down using sera against POT1, TPP1, and TRF2 (Fig.9A 
and B) in HTC75 and HeLa 1.2.1.1 over-expressing the protein. Additionally MYC-TPP1, 
MYC-POT1∆OB and FLAG-TRF1 could be found to co-immunoprecipitate both with p180 and 





Figure 9. Interactions between POLA2 and Shelterin components detected by IP-Western 
in HTC75 and HeLa 1.2.1.1.overexpressing MYC-POLA2. 
A. Extracts prepared from HTC75 cells expressing MYC-POLA2 were used for 
immunoprecipitations with the antibodies indicated at the top of the lanes. B. 
Immunoprecipitation in HeLa 1.2.1.1 expressing MYC-POLA2 done as explained in A. 
The antibody used to probe the Western blots was anti-MYC 9E10 antibody.  
Quantitation for both experiments was done by subtracting the PI signal from the S signal. PI: 
preimmune serum, S: immune serum. All samples shown for each line were part of the same 
experiment and on the same membrane, except for TRF2 pull down for HeLa 1.2.1.1 which 
came from the same experiment, but from different membranes. Total vector is a negative 
control for no expression of the tagged proteins. 





Figure 10.  Interactions between Pola and Shelterin components detected by IP-Western in 
HCT75 overexpressing tagged proteins. 
Extracts prepared from HTC75 cells expressing tagged constructs, shown on the right, were used 
for immunoprecipitations with the antibodies indicated at the top of the lanes.  The antibodies 
used to probe the Western blots were anti-MYC 9E10 antibody and anti-FLAG M2 antibody. 
Quantitation was done by subtracting the PI signal from the S signal. PI: preimmune serum, S: 
immune serum. All samples shown for each line were part of the same experiment and on the 
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The amounts of p180 and p68 observed at telomeres could be the result of direct 
interactions at the protein level with both the CST and Shelterin complexes.  Since these 
interactions can be detected with the N-terminal deletion of POT1 lacking the DNA binding OB 
fold (POT1∆OB), it appears that this domain is not required for the associations observed here. 
I tested if these interactions could also be observed at the endogenous level in HeLa II 
cells by using sera against Shelterin components and OBFC1. The western for the IP was then 
probed with antibodies against p68. Endogenous p68 was detected interacting with TRF1, TRF2, 
TPP1, and OBFC1 (Fig. 11) confirming what was seen with the overexpressed proteins that the 
protein can be found in complex both with Shelterin and CST. Interestingly, both MYC-OBFC1 
and p68 were pulled down by antibodies against hTERT (Fig. 8A and Fig. 11) hinting at another 
interaction between the lagging strand machinery and telomerase. Such an interaction has been 
detected in yeast, between CST and Est1, and in ciliates [56], but never in human cells. In 
addition, preliminary data show that telomerase activity can be observed with p180 pull-down in 
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Figure 11.  Interactions between Pola and Shelterin components detected by IP-Western in 
HCT75 overexpressing tagged proteins. 
Extracts from HeLaII were used to pull down endogenous p68 using the antibodies indicated on 
top of the lanes. p68 commercial antibody was used to probe the membranes. Quantitation was 
done by subtracting the PI signal from the S signal. PI: preimmune serum, S: immune serum. All 
samples shown for each line were part of the same experiment. However, p68 and p180 and 
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Figure 12. Telomerase activity detected with p180 immunoprecipitation. 
TRAP assay was performed on HeLa 1.2.1.1 extract . The first two lanes correspond to the 
original extract and the control reaction with an RNase treated extract. Lane 3 shows the 
background from the beads used for IP. Lanes 4 and 5 correspond to the immunoprecipitation for 
p180. PI: pre immune. S: Serum. The sample used for immunoprecipitation with the p180 serum 
was treated with RNAse as a control reaction in lane 6. The last lane, lane 7, is a control reaction 
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Discussion 
 
In this study I report a novel interaction between the components of the Polα/primase 
complex and Shelterin in humans using co-immunoprecipitation. It is possible that this 
interactions, suggested also by ChIP results showing p180 and p68 localization at telomeres, are 
mediated by CST.   
 As CST is known to interact with both complexes, it is possible that it works as an 
intermediary between the other two sets of proteins possibly modulating C-strand fill in. In fact, 
the complex does not seem to have an active role in the recruiting of Polα/primase complex to 
telomeres as initially believed. Of interest was also the pull down of OBFC1 and p68 with 
hTERT, the catalytic subunit of telomerase. This is an interaction that needs to be further studied 
and confirmed, but it hints to the coordination of telomeres elongation and C-strand fill in and at 
an interaction between telomerase and Polα/primase that has been seen in other organisms. 
ChIP data supports the notion that both p180 and p68 can be detected at telomeres 
notwithstanding the ostensible transient interaction between the complex and the DNA, required 
for replication. In addition, the results suggest a possible role for p68 at telomeres independent 
from general genomic replication in view of the low, but consistent presence of the protein at 
telomeres throughout cell replication. In yeast, p68 is believed to be important for the loading and 
the priming of the complex on the template [88]. Its interaction with overexpressed Stn1 seems to 
support a possible role for the p68 in the loading of the CST complex to DNA. This could be even 
more fitting in higher eukaryotes telomeres, particularly as new data is emerging defining the role 
of the CST complex more as a modulator of Polα/primase activity [72, 74] than as involved in the 
replication complex loading on the template. It is possible that p68 stable presence at telomeres is 
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indicative of this function at a site inherently problematic for general replication, which 
additionally requires further processing in the form of C-strand fill-in and where reloading of he 
complex is required even after general replication has taken place. p68 presence may also 
underscore some other telomeric role that is not directly linked to replication, as it has been 
hypothesized for other proteins that normally have other cellular roles, as exemplified in the 
interaction between TRF1 and ATM [104]. 
As previously mentioned it has be noted that telomeric signal obtained from CHIP done 
with Shelterin components may be more representative of the presence of the proteins at 
telomeres than relating to the actual ratio between the abundance of the proteins in the cell and 
their binding at telomeres. Similarly the percentage representing the presence of p180 and p68 at 
telomeres, particularly if representing an interaction of the two replication factors with shelterin 
proteins, may give us a hint of the behavior of the two factors at telomeres. The low percentage 
obtained for p180 stresses the transitional nature of the protein function at telomeres. 
Based on Takai et al [21] study on the stoichiometry of shelterin at telomeres it is known 
that some of the shelterin components, namely TRF1 and TRF2, can be found not exclusively 
bound to telomeres. Hence some of the interactions observed in the CO-IP may happen in the 
nucleus but not necessarily at telomeres. It would be interesting to do some cell fractionation and 
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 CHAPTER 4 
 





As I was able to observe components of the Polα/primase complex at telomeres and to 
establish a novel interaction for p68 and p180 with Shelterin either directly or through the CST 
complex, I sought to determine a specific role for the complex at telomeres. 
Altering telomere homeostasis can bring on telomere dysfunction, which is usually linked 
to critical shortening of telomeres or to telomeres de-protection. The end result ranges from 
senescence to apoptosis going through various levels of chromosome instability, and specifically 
chromosome end-to-end fusions. Telomere dysfunction is often accompanied with telomere 
dysfunction induced foci (TIFs), which are the result of the accumulation of proteins involved in 
the DNA damage response, such as 53BP1 and γH2AX at telomeres when they are perceived as 
de-protected and a site of DNA damage. TIFs can be localized specifically at telomeres through 
the co-localizations of the DNA damage proteins and Shelterin components. An example of 
alterations that can result in TIF is the depletion of Shelterin proteins TRF2, resulting in 
activation of ATM, and POT1, leading to activation of ATR.  
The ATR pathway is triggered in response to DNA replication stress and single stranded 
DNA accumulation, through the loading of RPA on the single strand DNA present at the site of 
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DNA damage.  There, RPA is able to recruit ATR to the site through ATRIP, a protein found in 
complex with ATR.  ATR is then activated by TopBP1 and subsequently phosphorylates a set of 
downstream targets responsible for cell cycle arrest and DNA repair, notably Chk1 [105]. In fact, 
Chk1 is used as a marker of the ATR pathway activation.  
The ATR response, both in mouse and human, can be activated at telomeres upon loss of 
POT1, resulting in TIF formation and Chk1 activation, but without strong effects on cell growth 
or chromosome integrity [52]. In mouse, it was shown that the unprotected overhang, resulting 
from depletion of POT1a, resulted in the recruitment of RPA to the telomeres, particularly during 
S/G2, and in the triggering of the ATR pathway [53]. ATR also transduced the DNA damage 
signal originated from telomeres after TRF1 removal [51]. Although, this signal was not due to 
overhang accumulation at telomeres, as is the case for POT1, but to replication stress, such as 
replication fork collapses or secondary structures adopted by the strands being replicated, for 
instance G-quartets, which specifically rendered telomeres fragile replication sites [27]. Hence, 
inappropriate activation of ATR signaling transpires because of the nature of the telomere itself: 
the presence of a single stranded overhang or its intrinsic feature as a fragile site.  
By altering the lagging strand machinery expression I hypothesized that telomeres could 
experience a similar fate to the one described above, due to replication stress or to the creation of 
single stranded DNA structures. As other sites on the chromosome could possibly face the same 
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Results 
 
In order to study the roles of p180 and p68, I depleted both proteins by siRNA (Fig. 13A 
and C) and for p68 by shRNA in HeLa II cells (Fig. 18). Among the three siRNA targets used for 
p180, the depletion was consistent at about 70% of control endogenous levels (Fig. 13A and B).  
For p68, the first target site had a mild effect at about 50% depletion, and the second one yielded 
a somewhat higher depletion (Fig. 13C and D).  The intermediate levels of depletion correlated 
with mild effect on cell cycle progression, with no obvious defect in the case of p68 siRNAs, and 
a slight delay in S/G2-M phase in the case of p180 siRNA (Fig 14A and B).  The modest 
increase in S/G2-M phase cells was correlated with a similar decrease in G1 cells. The depletions 
observed in this study are similar to previously reported ones [106] and may explain our capacity 
to detect the telomeric effects described here without major inhibition of cell cycle progression.  
Knock down of p180 generated a broad DNA damage response in the cell, as judged by the 
induction of p53BP1 foci (Fig. 15A). The effect was not observed upon depletion of p68.  The 
average number of nuclei with p53BP1 foci went from about 30% in control or p68 siRNA, to 
over 50% with p180 siRNAs (Fig. 15B). This observation likely corresponds to a broadly 
localized induction of DNA damage, as opposed to a telomere de-protection phenotype, since no 
obvious co-localization with telomeres was observed. The DNA damage response seen with 
p180 depletions is compatible with replication stress, as a significant activation of Chk1 was 
observed (Fig. 16A and B). The Chk1 phosphorylation response corresponds to what was seen 
with immunofluorescence, with over 15 fold increase in phosphorylated Chk1 in the p180 siRNA 
samples and a null or mild response in the p68 siRNA samples. 
 









Figure 13. Depletion of p68 (POLA2) and p180 (Polα) in HeLaII.  
A. Western blot showing p180 knockdown by three different siRNAs B. Quantitation of p180 
depletion C. Western blot showing p68 knockdown for two different siRNAs D. Quantitation of 
p68 depletion. Cells were collected 48 hrs after treatment. For the quantitation, the relative ratio 
was obtained by normalizing the p180 and p68 signal to GAPDH and dividing by the untreated 


















Figure 14. FACS of siRNA treated cells 
A. FACS data showing DNA content of HeLaII untreated and treated with siRNA for p68 and p180. 
Cells were collected 48 hrs after treatment. B. Quantitation of the cells found in subG1, G1, S, and G2 




































Figure 15. Depletion of 180, but not p68, leads to increased p53BP1 DNA damage foci. 
A. Immunofluorescence detection for p53BP1 foci in HeLaII cells 48 hours after siRNA treatment 
for p68 or p180. One set for each siRNA is shown. Blue: DAPI; Red: p53BP1; Green: TRF2. B. 
Quantitation of p53BP1 foci in HeLaII cells treated with p68 and p180 siRNAs. A hundred nuclei 













Figure 16. Depletion of 180, but not p68, leads to Chk1 activation 
A. Western blot showing pChk1-Ser345 for the controls and siRNA samples. B. Quantitation of Chk1- Ser 
345 phosphorylation. For the quantitation the relative ratio was obtained by normalizing the pChk1-Ser345 
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Discussion 
 
As a certain basal amounts of the Polα/primase complex components can be found in the 
cells independently from the E2F driven increase observed before replication, it is possible that 
even a dramatic decrease in p68 and p180 as the one I was able to obtain with siRNA treatment 
will not completely derail the duplication of genomic DNA. Although, the disruption of 
Polα/primase complex led to an ATR-dependent DNA damage response in the case of p180 
depletion, illustrated by the increase in 53BP1 DNA damage foci observed by 
immunofluorescence, the depletion was accompanied by a mild S phase delay, but not by any 
other more deleterious phenotype, as previously shown by Chattopadhyay et al. [106]. 
Considering the tight interaction between p68 and p180, it was surprising that no overt effects on 
cell cycle progression or induction of DNA damage were observed in p68 knock down 
experiments.  
It is possible to explain the different cell cycle and DNA damage phenotype by 
understanding the role of the two different proteins in the complex and how the lagging strand 
machine functions. 
Although, the minimal amount needed for the Polα/primase complex components to 
accomplish their function is not known, Chattopadhyay et al.[106] showed that even small 
amounts of p180 were sufficient to support replication, and studies in primary cells show that 
limited amounts are needed to carry on replication and that the levels decrease to almost 
undetectable as the cells approach senescence. This is possibly due to the fact that its function 
relies on being constantly reloaded on the template. 
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Based on my data (Fig. 6), showing a consistent presence of p68 on the template 
throughout the cell cycle, and studies in yeast that suggest that the regulatory subunit is loaded 
on the template at the end of the G2/M cycle, it is possible that even a limited amount of p68 
could fulfill its regulatory function on the chromatin. It has also been shown, in mouse, that p68 
is instrumental for p180 stability and ability to travel from the cytoplasm to the nucleus [94], but 
that the primase and catalytic subunits can fulfill their function independently from the 
regulatory subunit once loaded on the template [80, 81], These observations of the working of 
the complex stress the need of a tight coordination between the components of the complex at 
different stages of DNA replication and hint to the possibility that the phenotypes, or lack 
thereof, for DNA damage and cell cycling progression for the knockdown of p180 and p68 are 
due to a lack of coordination between regulatory and catalytic subunit. 
When p180 is depleted in HeLa p68 levels are unchanged (data not shown). The 
regulatory subunit most likely is not affected and fulfill its regular function, loading on genomic 
DNA at the end of replication in the nucleus and ostensibly binding to p180 in the cytoplasm to 
allow for its transport in the nucleus and consequent loading to the appropriate replication sites. 
However, when p180 is not available in enough quantity it is possible that a bottleneck occurs in 
the cytoplasm where p68 is unable to retrieve enough p180 in a timely manner for nuclear 
relocation, resulting a slight slowing down of the cell cycle, as observed in Figure 14. However, 
enough p180 is eventually shuttled to the nucleus and loaded on the template to fulfill 
replication. It would be of interest to extend the treatment to see how long the cells would be 
able to withstand this situation.  
The lack of coordination between the p68 and p180 could also explain the increase in 
Chk1 activation in cells depleted of p180 without the expected deleterious effects. Polα/primase 
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loading at DNA damage sites through TopBP1 is necessary for the activation of the ATR 
pathway [107, 108], more specifically the loading of the catalytic subunit. As the cell cycle is 
slowed due to lack of p80, there is most likely an increase in stalled forks, which results in the 
increase in cells in the S/G2 phases observed in the FACS experiments. The activation of the 
ATR pathway would be permitted by the presence of p68 that would allow the loading of p180, 
and consequent activation of Chk1, at the DNA damage site. Due to decrease of p180 and the 
more laborious complex loading process, the DNA damage signal, represented by an increase in 
53BP1 sites and pChk1, would be strong, but the amount of proteins present would be enough in 
time to overcome the setback, at least in cancer cells. Similar events, where the DNA damage 
pathway was clearly activated as per 53BP1 foci observed in the nucleus without dramatic 
effects on the life of the cells, were observed with at least two shelterin proteins, TRF2 and 
POT1. In both cases, the depletion of the protein, in a small percentage for TRF2 as complete 
depletion brings on dramatic chromosomal defects, brought on the formation of 53BP1 foci 
which, as in my data, where not found to localize at telomeres, but hinted to a more general 
response. In both cases, as with p180, cancer cells seemed to be able to withstand the stress and 
continue replicating. Experiments done in primary cells, however, resulted in them senescing. It 
would be interesting to perform the siRNA experiment on primary cells and see if similar results 
in terms of DNA damage and cell cycle progression would be observed by depleting p180 and 
p68. 
The phenotype observed with the depletion of p68 is somewhat more puzzling, 
particularly considering the data from Mizuno et al. [109] where co-expression experiments of 
p68 and p180 show that the expression of the regulatory subunit is crucial for the expression of 
p180 and in experiments with siRNA for p68 in HeLa (not shown) where its depletion 
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proportionally affects the levels of p180. I believe this, too however, relates back to the need of 
coordination between the various components of the Polα/primase complex.  While p180 
stability and levels are sensitive to variation of other components of the replication machine, ex. 
Mcm10 [106], p68 levels seem to be independent from other factors. It is conceivable that the 
regulation exerted by p68 on the catalytic subunit involves a more refined system that includes 
control on the translation of p180, as Mizuno et al. hypothesized, or maintenance of the protein 
when the cell replication program is initiated. The need for coordination between the two 
subunits would allow the replication process to proceed unheeded, albeit at a lower pace, when 
p68 is depleted as p180 assembly would be equally held up. Although, a delay in replication was 
not observed in my siRNA samples, it is plausible that a clear effect on cell replication may take 
time and would not be detected by FACS, but by looking at the length of time it takes the cells to 
duplicate. It was in fact observed in HeLaII stably transfected with p68 shRNA, that the ones 
treated with the most effective shRNAs, namely sh664 and sh3’UTR, had an extended division 

















Although I was able to demonstrate the presence of both p68 and p180 at telomeres and 
that they interact with Shelterin, their knockdowns did not induce any TIF formation. Knock-
down of p180 resulted in a general increase of DNA damage foci in the nucleus, while in the 
case of p68 the DNA damage was found to not even be over the basal level observed in cancer 
cells (Fig.15). That raised the question of the role, if any of the complex at telomeres. To test if 
indeed changes in the amount of Polα/primase components would result in changes at the 
telomeres I looked at specific telomeres features related the processing of the terminal structure: 
overhang and total telomeres length. 
Studies in yeast and mouse on the effects of mutations in the Polα/primase complex 
showed that they can affect telomere and overhang length [61], in S. cerevisiae probably due to 
the direct interaction with the CST (Cdc13-Ten1-Stn1) complex [55]. This led us to investigate 
overhang and 5’end processing in cells treated with siRNA for p180 and p68 and stably 
transfected with p68 shRNA using in-gel overhang hybridization. 
A decrease in the length of the overhang would stress the complex protective role at 
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telomeres and could bring on greater telomeric degradation. Such an event has been observed in 
yeast, but not in mammalian cells, where I would expect such a condition to activate DDR, cell 
cycle arrest or apoptosis.  
An increase in the overhang length could point to a defect in the processing of the 
complementary 5’end either due to lagging strand processing or 5’C-strand fill-in. In addition, 
telomeric 5’end processing is under strict regulation, and is dependent on POT1 [57] ; in fact, as 
mentioned wild type cells have 80% of their 5' C-strand ending with AATC-5', and 15% with 
AATCC-5' and depletion of POT1 by shRNA randomizes the terminal nucleotide [49, 57]. Not 
much is known about this process and the proteins involved, POT1 excluded. As it may be 
associated either with C-strand resection or fill in, I decided to test cell treated with the siRNA 
and the shRNA also for the terminal nucleotide.  
In our experiment, overhang length was determined using native non-denaturing 
hybridization measured by conventional Southern blot for telomeric DNA.  
Regulation of 5’end processing was assessed using STELA (single telomere length assay) 
a well characterized method published first by the Kipling laboratory (Cardiff University, Wales) 
[110] and modified by the Shay and Wright laboratories (UT Southwestern) [57].  
Briefly, this protocol entails ligating a specific oligonucleotide that hybridizes to the G-
strand but ends at one of the six permutations of the telomeric repeat (the "telorette"). Each 
telorette contains a unique sequence, the "teltail” that is used as a PCR target site. Six separate 
ligation reactions with genomic DNA and one of the telorettes are performed, and the ligated mix 
is amplified with the teltail primer and the XpYp primer, specific for a subtelomeric sequence on 
the human X and Y chromosomes. The products of the PCR are then detected by Southern blot 
with a subtelomeric XpYp probe. Wild type cells have 80% of their 5' ends ending with AATC-
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5', and 15% with AATCC-5'. I hypothesized that like the components of the other two 




As both Shelterin and CST play important roles in telomere protection through overhang 
processing, I looked at the telomeric overhang in conditions where p180 or p68 were depleted. I 
looked at both short-term depletion via siRNA for both p68 and p180 (Fig.13A and C) and long-
term depletion using shRNAs for p68 (Fig. 24).  As previously mentioned HeLaII treated with the 
siRNAs, most particularly against p68, did not show any specific phenotype in terms of DNA 
damage or cell cycle alterations. However, in-gel hybridization revealed that depleting p68 and 
p180 led to a significant increase in the telomeric single stranded G-overhang length in a range 
corresponding to 10-40% for p68 and up to 50% for p180 (Fig. 17A, B) The increase seemed to 
be positively correlated to the siRNAs, si-p68-2 and si-p180-2, which on average are the more 
effective (Fig.13B and D). Similar results were observed with the p68 shRNAs. The shRNAs 
were introduced in HeLaII cells through retroviral transduction. p68 was knocked down using 
four different shRNAs targeting different sites on the predicted mRNA (Fig. 18). Once the cells 
recovered from selection they were maintained and collected at sequential population doublings. 
Cells infected with sh664 and sh3’UTR took longer to recover from selection and to divide. It 
was observed that of the four shRNAs those were the one that showed a greater decrease in the 
protein, with sh5’UTR and sh1088 showing almost no decrease. After the initial delay in 
proliferation, however, the cells kept growing without further apparent defects, and exhibited a 
milder level of depletion as the passage increased (Fig.18). In this case in-gel hybridization 
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showed a 10-15% increase in overhang length with a stronger effect seen for sh664 and sh3’UTR 
(Fig. 24) and almost no effect seen for sh5’UTR and sh1088. In addition, the effect in the shRNA 
samples was stronger in the earlier passages and subsided as the passages increased 
concomitantly with the lessening of the p68 depletion observed in the Western Blots (Fig.18).  No 
change in overall average telomere length was observed by Southern Blot (Fig.20), although, this 
may also have been due to the decreasing effect of the shRNAs with the increase in the 
population doublings. 
To test if the replication proteins had any involvement with the processing of the last 
nucleotide of the 5’ strand, STELA experiments were done both on cells with stable p68 shRNAs 
or treated with p180 and p68 siRNA. While some samples showed hints of randomization, the 
































Figure 17. Increased overhang amounts upon siRNA depletion of p68 and p180. 
A. In-gel hybridization for HeLa treated with siRNA for p68 and p180. Genomic DNA restricted 
with MboI-AluI and ran on a 0.7% agarose gel. Left panel: native gel probed with the labeled 
oligonucleotide (CCCTAA)4 hybridizing to the telomeric overhang.  Right panel: same gel 
reprobed after denaturation to detect all telomeric sequences.  Samples treated with ExoI were 
run as controls for overhang detection. B. Overhang intensity was calculated by finding the ratio 
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Figure 18. Increased overhang amounts upon shRNA depletion of p68. 
A. In-gel hybridization for HeLa treated with shRNA for p68 at passages 2 to 10. Genomic DNA 
restricted with MboI-AluI and ran on a 0.7% agarose gel. Left panel: native gel probed with the 
labeled oligonucleotide (CCCTAA)4 hybridizing to the telomeric overhang.  Right panel: same 
gel reprobed after denaturation to detect all telomeric sequences.  Samples treated with ExoI 
were run as controls for overhang detection. B. Quantitation of overhang intensity for shRNA 
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Figure 19. Depletion of p68 (POLA2)by shRNA in HeLaII.  
Western blot showing p68 knockdown for four different shRNAs at increasing population 
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Figure 20. Terminal nucleotide composition at telomeric C-strand for HeLa II with 
depleted p68.  
Individual telomere products generated by the STELA assay in HeLa II cells treated with four 
different shRNAs for p68. LMP is the vector control. Each telorette was used in an independent 
assay and run in independent lanes.  
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Figure 21. Total telomeres length in HeLaII treated with shRNA against p68. 
DNAs from HeLaII cells expressing the indicated shRNAs were harvested at increasing 
population doublings after infection and selection and analyzed for TRF lengths by Southern 
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Discussion 
 
These results suggest that the amount of p68 and p180 in the cell had a clear effect in the 
regulation of overhang length. Based on this observation I speculate that either telomeric 
replication and/or in 5’C –strand processing or both were affected. The overhang increase seen in 
both siRNA and shRNA treated cells suggests that p68 and p180 play a role in the regulation of 
the length of the telomeric overhang. This is interesting in the context of recent findings that the 
length of the overhang was determined by where the last primer was laid [60]although what 
determines the parameter for the last loading is still not clear. Based on the STELA, in fact, 
changes in the levels of Polα/primase complex have no detectable effects on the nature of the last 
nucleotide of the 5’C-strand. This could point to POT1 as the molecule responsible for the 
positioning of the last primer.  
One possible model is that Shelterin, CST, and Polα/primase form a transient complex 
that is responsible for placing the primer on the parental overhang and then leads to 5’ C-strand 
processing. The processing of the 3’ strand does not appear to be dependent on Polα, but could be 
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CHAPTER 6 
 Concluding  Remarks 
 
The results presented here provide a link between the Polα/primase complex, and two 
other telomeric complexes, Shelterin and the CST complex.  While Shelterin and CST have 
documented roles in telomere function, having an impact both on the protection and maintenance 
of telomeres, the implication of mammalian Polα/primase in the processes that I described here is 
novel.  Is its role at telomeres related to conventional chromosome DNA replication, or are there 
telomere-specific, non-canonical roles for Polα/primase at telomeres?  Although the final answer 
requires additional work, I would argue based on my findings that the observed effect on 
overhang processing reflects a telomere-specific role for Polα/primase not related to origin-
initiated DNA replication.   
I report here for the first time an interaction between p180, and p68 with Shelterin (Fig. 
9, 10 and 11). This type of associations was described, mostly genetically, in budding and fission 
yeast [62, 111] but never to my knowledge in mammalian cells. I was also able to observe 
significant effects on overhang length (Fig. 16) without evident general DNA damage activation 
for p68 depletion (Fig.15 and 16), arguing for efficient DNA replication in our conditions.  These 
observations could be simply explained by arguing that the remaining amounts of p68 in our 
depletion experiments are sufficient to support DNA replication, but limiting for effective 
overhang processing.  There is also a second possibility, that the increase in overhang length 
could reflect a higher dependence on the regulatory subunit for effective overhang processing at 
telomeres than for conventional DNA replication.   This would underscore a telomere-specific 
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set of events implicating Polα/primase. Such a role could be highly conserved in evolution, and 
be related to the finding that a special mutant allele in the budding yeast POL12 gene, which 
corresponds to the p68 ortholog, displays deregulated telomere function, including longer 
telomere length, and telomere deprotection, as well as genetic interactions with STN1, the 
OBFC1 ortholog [55]. In human cells, dominant-negative approaches, with constructs targeting 
the p180/p68 interacting domains could allow for a finer analysis of telomere-specific functions 
for Polα primase. I would also speculate that the role of Polα at telomeres requires a specific 
interplay with telomerase, which would explain the observation that the length of the overhang, 
albeit variable, is regulated. This coordination would be of a novel biochemical nature, different 
from chromosomal DNA replication, requiring an interface between a DNA polymerase (Polα) 
and a reverse transcriptase (hTERT). More work is required to demonstrate such interactions. 
An important future direction will involve the understanding of the mechanism of action 
of Polα/primase at telomeres, if different from or more complex than mere association with the 
replication fork progressing through the telomere.  At present, it is valuable to interpret these 
results in light of recent work showing that the CST complex, in particular OBFC1, limits 
telomerase activity, thereby participating in telomere length homeostasis [73] and could have a 
specific roles in C-strand fill in [112]. Knowing that OBFC1 is part of an “alpha activating 
factor” complex [63] but seemingly has no role in the recruitment of the protein at telomeres, 
leads us to suggest that Polα/primase, through p68 is recruited through telomere-specific 
interactions, perhaps involving Shelterin, to lay down the terminal RNA primer and restrict the 
length of the overhang. It is interesting to note that in mouse cells POT1b is proposed to be the 
recruiting activity for the CST complex [55].  Our data is compatible with this view, and it would 
be valuable to test the possibility that POT1 is the recruiting factor for CST and Polα in human 
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cells, particularly in view of the fact that an interaction was observed even when the protein was 
missing the DNA binding OB-folds.  Depleting amounts of Polα/primase would render this step 
limiting and result in increasing overhang length overall.  According to this view, the overhang 
phenotype reported here is predicted to be dependent on telomerase activity, and it would thus be 
interesting and important to perform the depletion experiments for p68 and p180 in telomerase-
negative primary cells. An increase in the length of the overhang in this case would point to a 
specific activity in laying the terminal primer for lagging strand synthesis, which, when impaired 
of diminished, would result in longer stretches of unreplicated overhang. However, if primary 
cells would not show any increase in the overhang, it would clearly point at a connection 
between the 3’overhang extension by telomerase and the coordinate fill-in that needs to happen 
for appropriate telomeric maintenance. This could indicate a specific target in cells with active 
telomerase and confirm the coordination needed between telomerase and lagging strand 
machinery, which could be carried on through TPP1 or possibly through a direct interaction 
between the sets of proteins, as hTERT was pulled down by p68 in endogenous western blots. 
This would also mean that this Polα/primase telomere specific function could be targeted in 
tumor cells, for instance, to limit their proliferation.   
I did not detect obvious telomere de-protection (by looking at p53BP1foci) in either p180 
or p68 siRNA treated cells and neither did I see dramatic effects at the level of cell cycle; hence, 
this pathway for overhang processing is not expected to lead to immediate effects such as 
apoptosis or premature senescence.  However, one could hypothesize that the lack of effective 
fill-in synthesis would exacerbate the so-called “end replication problem” and limit the 
proliferative potential of cells, perhaps even of telomerase-positive tumor cells. Longer-term 
experiments than those reported here would be required to examine this possibility. As shRNA 
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lines for p68 showed, however, knocking down of the proteins may in the long run bring on 
selection for less sensitive cells in the population, thus, a dominant-negative approach may be 
valuable also in this case. 
The second issue is whether the overhang phenotype requires cells to be passing through 
S phase, or whether the specific function of Polα/primase suggested here is independent of actual 
DNA replication.  Even though I did detect an increase in p68 and p180 at telomeres in S phase, 
it remains a possibility that some of these interactions occur outside of the context of DNA 
replication. Therefore, it would be valuable to assess the possible effects of Polα/primase in cells 
that are in G0, which do not experience progression through the cell cycle, S phase or 
proliferation. 
It would also be interesting to explore the interaction and significance of the replication 
complex with CST, and specifically OBFC1. This could be done by knocking down both p180 
and p68 concomitantly with OBFC1 and analyze if the resulting phenotypes are similar, or 
additive to the one observed in the single knockdown.  
As replication and the ability of Polα/primase to function are controlled by p68 and p180 
phosphorylation, it would be of great interest to observe the two proteins phosphorylation status 
during the cell cycle and after siRNA treatment. Particularly it would be interesting to compare 
the phosphorylated status of p180 in cells where p68 has been knocked down as potentially one 
of the phosphorylated forms that is relevant for telomeric processing is affected. 
Overall, my work contributes in describing interactions between three major complexes 
at telomeres: Shelterin, CST and Polα. These and other studies raise interesting questions for the 
future of the telomere field and may provide insights into targeting cell proliferation, or inducing 
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Appendix 
 
POT1 Knock Out 
POT1 
 
POT1 is the only protein in the complex that binds to the single stranded overhang. The 
binding is highly sequence specific to the G-strand, and occurs with high affinity (~5nM) [45, 
46]. The protein was identified in a database because of its homology with TEBPα, the telomeric 
ssDNA binding protein in O. nova [47]. POT1 is composed of three domains: two OB folds, 
necessary for binding to the DNA, and the C-terminal third of the protein, which contains the 
TPP1 binding domain essential for recruitment of POT1 to the Shelterin complex. 
The role of POT1 was studied by creating deletion mutants for the first OB fold and for 
the C–terminus, and by siRNA and shRNA depletion experiments. Deletion of the C-terminus 
showed the importance of the TPP1-POT1 interaction for the recruitment of the protein to the 
telomeres [40] as the allele truncated for the C-terminal region, termed POT1ΔC, was not found at 
telomeres but rather accumulated in the nucleoplasm. 
Another informative allele, named POT1ΔOB, lacks the first OB fold and is unable to bind 
the single stranded DNA in vitro [46]. However, POT1ΔOB is fully proficient in binding to TPP1 
and therefore does localize to telomeres. Overexpression of this allele leads to rapid and 
extensive telomere elongation, with a rate of 280bp/division. The telomere elongation observed 
with POT1ΔOB showed that the DNA binding activity of POT1 exerts a repressive action in cis on 
telomerase, which established POT1, like TRF1 and TRF2 before, as a negative regulator of 
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telomerase. In fact, additional experiments placed POT1 in a telomere length regulation pathway 
dependent on TRF1 and TRF2 [48] 
The identification of POT1 as a negative regulator of telomere length was corroborated 
by POT1 depletion studies by shRNA [49] Upon depletion of about 90% of the protein, telomere 
elongation was observed, confirming a role for POT1 as a negative regulator of telomerase. 
These experiments also showed that POT1 function is important for telomere protection. In fact, 
upon depletion of POT1, DNA damage proteins such as p53BP1 were found to converge to 
telomeres, a process indicative of the detection of telomeres as DNA damage. Telomeres become 
sites of accumulation for γH2AX, p53BP1, MRE11, MDC1 and these foci are referred to as 
telomere dysfunction induced foci or “TIFs” [50, 51]. In the case of POT1 depletion, TIF 
formation did not affect cell growth or chromosome integrity [49] However, the accumulation of 
DNA damage at telomeres resulted in premature senescence [113]. These results indicate that 
significant depletion of POT1 can occur without a major impact on cell viability.  
POT1 depletion highlighted another important role for the protein, its function in the 
processing of the 5’ C-strand. In humans, it was observed that while the 3’ G-strand final 
nucleotides could be randomly placed, the same could not be said for the complementary 5’ C-
strand, which was determined to end in AATC-5’ eighty percent of the times and in AATCC 
fifteen percent of the times [49] . This highly controlled system was derailed by POT1 depletion, 
which brought on randomization of the 5’ C-strand terminal nucleotide.  
The conclusions drawn from these studies are that the overhang binding activity of POT1 
bears two important activities: repression of telomerase and the protection of telomeres from 
recognition by the DNA damage machinery [38]. Even though, these conclusions for the role of 
POT1 are generally accepted, some published data implies the possibility that POT1 could have 
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a dual role and also behave as a positive regulator of telomerase. This alternative conclusion is 
based on experiments in which overexpression of POT1 led to clones with elongated telomeres 
[114]. In addition, biochemical experiments on model telomeric seeds show that purified POT1-
TPP1 complexes can increase the repeat addition processivity of telomerase in vitro [41]. 




None of the experimental setups examined so far completely eliminate the effects of 
endogenous POT1. Although clear effects are seen upon mutant overexpression and shRNA 
depletion, one cannot forget that neither technique guarantees the complete silencing of the 
endogenous protein. It is possible that even low amounts of wild-type POT1 at the telomeres can 
still provide important activities. In the shRNA studies it was estimated that 5 to 10% of the 
endogenous protein was still present in the cells [49]. As for the POT1ΔOB mutant, endogenous 
full-length POT1, albeit in reduced amounts [48], could still hypothetically participate in the 
recruitment of telomerase. One way to have a clear answer to the role POT1in the maintenance 
and protection of telomeres is to create a conditional knockout of the gene in human cell lines. 
This should allow us to learn if POT1 is essential for cell survival and to pinpoint its role in the 
processing of telomeres in term of telomerase elongation and in terms of its interaction with 
DNA damage, repair, and replication complexes. Knock out experiments of this kind have 
already been performed in mouse [115]; however, there are some differences between mouse and 
human telomere biology that justify our focus on the human cellular system. First, telomeres in 
the common laboratory mice are over 50kb, much longer than human telomeres, making them 
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unsuitable for telomere length studies. In addition, the mouse genome possesses two POT1 genes 
with specialized roles, which may be carried out by the unique POT1 gene in humans. Therefore 




In order to understand more about the role of POT1 at telomeres and in 5’end processing, 
I tried to create a human POT1 conditional somatic KO in HCT116 cancer cell lines. 
For this purpose, I began the process in the HCT116 cell line applying a technique for 
conditional gene KO previously described by the Vogelstein laboratory and that has been 
successfully used to create conditional securin knockout in human cells [116]. The specific 
protocol I was using, was provided by Dr. Prasad Jallepalli (Sloan Kettering Institute, 
Department of Molecular Biology). Cell lines bearing respectively one targeted POT1 allele and 
a KO allele were obtained. 
The strategy used to create the targeting construct had to be adjusted to the particular 
characteristics of the POT1 gene for which the straightforward deletion of the initial ATG found 
in exon 1 was not desirable, as another in frame ATG is found in exon 4 of the POT1 gene. The 
downstream ATG site drives the translation of an alternative isoform of POT1 with a spliced out 
exon 3 that translates into an N-terminal truncated protein (Fig.21) [49]. The shorter POT1 form, 
called POT1-51, can be found in human cell protein extracts albeit in much smaller amount than 
the full-length protein. The POT-51 isoform, as POT1ΔOB, leads to telomere elongation upon 
overexpression. It is therefore essential to avoid production of POT1-51 in our conditional knock 
strategy. 
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Furthermore, targeting of exon 4 was also forgone, as it would lead to an in-frame 
deletion since both exon 4 and 5 are composed of multiple of three nucleotides. It was, therefore, 
decided that exon 6 would be the target of the conditional allele. The result of the deletion would 
affect the second OB fold, and as both OB folds are necessary to bind DNA [46], the predicted 
protein should be unable to do so. The truncated protein would lack the TPP1 interaction domain 
and it would consequently be incapable to associate with Shelterin at telomeres [40]. Hence, 
even if stable enough to be present in the cell, the predicted protein should not interfere with the 
phenotypic analysis of POT1 loss. 
The targeting vector was constructed by creating two arms for homologous 
recombination; exon 6 flanked by loxP sites; and the Neo resistant gene flanked by FRT sites and 
then cloned into an adeno-associated viral vector (AAV). 
One clone (#87) positive for the legitimate construct integration as confirmed by 
Southern blot (Figure 22) was obtained. Clone 87 NeoR was then transfected with the FLP 
recombinase expression plasmid pCAGGS-FLP to remove the Neo cassette. The procedure 
yielded five Neos clones. The clones were screened by PCR and Southern for loss of the Neo 
gene at the POT1 locus. The PCR strategy used involves amplification of the targeted exon with 
flanking oligonucleotides and allows the distinction of the wild type, targeted and deleted alleles. 
The Southern blot strategy confirms proper integration and makes use of an EcoRV site 
conveniently located at the POT1 genomic locus(Fig. 21). 
In addition, Clone 87 NeoR was transfected with H&R Cre recombinase in order to obtain 
a heterozygous cell line POT1+/Δ. One such clone was obtained, #109. The appropriate 
integration of the targeted allele was validated by Southern blot (Figure 19). 
The Southern blot strategy involves the detection of newly generated EcoRV fragments 
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given by an exogenous EcoRV site present in the targeting vector and two EcoRV sites present 
directly outside the left and right arm sequences, one on each side. Three probes to visualize the 
EcoRV fragments were created: a right arm and a left arm probe for the specific genomic 
sequences outside of the targeted region, but internal to the EcoRV site on each arm; and a Neo 
probe, specific for the Neo cassette. 
As mentioned POT1+/F and POT1+/Δ clones had been obtained. Both sets of clones were 
G418 sensitive and were re-infected various times for the second allele targeting. Unfortunately 
various infections of both POT1+/F and POT1+/Δ clones failed to produce clones that were G418 
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Figure 22. Schematic of the POT1 genomic locus and the targeting construct.  
See text for details. 
Exons are shown in red. The FRP sites are represented by diamonds and the loxP sites by 
triangles. The EcoRV sites are indicated by RV and the predicted fragments sizes are shown. 
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Figure 23 . Southern blot of genomic DNA extracted from infected HCT116. 
 Clone #87 (candidate targeted cell line), and clones thereof obtained by expression of FLP or 
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